Secure care hospital evaluation of art therapy

Not Applicable

• Conditions: earning disorders; Mental and Behavioural Disorders

• Registration Number: ISRCTN57406593
• Lead Sponsor: Cumbria Northumberland Tyne and Wear NHS Foundation Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-18
• Last Update Posted: 2 September 2024
• Study Completion: 2025-05-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Current inclusion criteria as of 28/02/2024:
1. An inpatient in an NHS secure hospital/unit/service with the presence of learning disability/borderline intellectual functioning indicated by either (a) meeting validated assessment criteria (recognised cognitive testing and adapting functioning assessment), or (b) a score of 57 or below on the Learning Disability Screening Questionnaire (LDSQ)
2. Age 18 to 60 years
3. Able to give informed consent
4. A HONOS (Health of the Nation Outcome Scale) score between 1 and 4 for item 1 (Overactive, aggressive, disruptive, or agitated behaviour / Behavioural problems directed at others)
5. The participants' involvement in the study is supported by their responsible clinician and/or multidisciplinary team (MDT)

Previous inclusion criteria:
1. An inpatient in an NHS secure hospital/unit/service with a Learning Disability Screening Questionnaire (LSDQ) score of 57 or below (indicating the presence of learning disability/borderline intellectual functioning/learning difficulty)
2. Age 18 to 60 years (within the age range for the service)
3. Able to give informed consent
4. A score between 1 and 4 on question 1 of the Health of the Nation Outcome Scale Working Age Adult or Learning Disability version (HONOS-WAA or HONOS-LD)
5. The patient’s involvement in the study is supported by their responsible clinician and/or multidisciplinary team (MDT)

Exclusion Criteria

Current exclusion criteria as of 28/02/2024:
1. Unable to give informed consent
2. Learning disability/borderline intellectual functioning not indicated based on a validated assessment or screening questionnaire (i.e. not meeting validated assessment criteria or a LDSQ Score >57)
3. A HONOS score of 0 for item 1
4. Planned discharge within 12 months of the start of the study
5. Unstable/unmanaged psychotic symptoms requiring active assessment or treatment including medication dose titration (i.e., dose adjustment in the previous 4 weeks or with potential further dose adjustment planned for the following 4 weeks)

Previous exclusion criteria:
1. LDSQ Screening score >57
2. Unable to give informed consent
3. A score of 0 on question 1 of the HONOS-WAA or HONOS-LD
4. Planned discharge within 12 months of the start of the study
5. Receiving active assessment or treatment for acute or unstable/unmanaged psychotic symptoms including medication dose titration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Aggressive behaviour is measured using the Modified Overt Aggression Scale (MOAS) at week 19, weekly between week 19-38, and week 38

Secondary Outcome Measures

Name	Time	Method
1. Health Economic analysis will be measured using the EQ5D, the Recovery Quality of Life Scale, and a resource use questionnaire, at baseline, week 19, and week 38<br>2. Patient distress attributed to psychiatric symptoms is measured using the brief symptom inventory and is measure at week 19 and week 38